Friday, May 9, 2025
Home 2024

Yearly Archives: 2024

All News

Adding Quantum Pharmaceutical (QNTM) $4.10 to Reverse Split Stock Watch List.

Editor / Curator -
2024 Watch List

Nine Page Summary Report on GeoVax (GOVX)

Editor / Curator -
2024 Watch List

GeoVax (GOVX) Provides First Half 2024 Business Update.

Editor / Curator -
All News

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

Editor / Curator -
Biotech News

FDA approves Amgen drug for tough-to-treat form of lung cancer.

Editor / Curator -
2024 Watch List

GeoVax Receives Massive $300+ Million BARDA Project NextGen Award!

Editor / Curator -
2024 Watch List

GeoVax (GOVX) Research Reports Archive

Editor / Curator -
2022 Watch List

Ardelyx (ARDX) Reports First Quarter 2024 Showing $204 Million in Cash!

Editor / Curator -
2024 Watch List

GeoVax to Provide Corporate Update on Tuesday May 14, 2024.

Editor / Curator -
2024 Watch List

NovaVax (NVAX) Roars Higher, Gaining 225% a $1.2 Billion Increase, at...

Editor / Curator -
123...6Page 1 of 6

Latest article

Zomedica Corp (ZOMDF) $0.05

Uncategorized Editor / Curator -
Company Overview Background Zomedica Corp., incorporated in 2013 under the Business Corporations Act (Alberta), is...

Gold prices plunge in biggest one-day drop in years. Is the record rally over?...

All News Editor / Curator -
Easing anxieties over Trump’s tariff policies and the Fed chair’s fate spark gold’s worst daily decline since 2021 Gold...

Gold Price Sets New Intraday Record Above $3,500 (WSJ)

All News Editor / Curator -
Gold hit another record Tuesday, then faded a bit in afternoon trading. The most actively traded futures contracts surged...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.